Last update:

Weight management news

Triple-action drug retatrutide delivers major weight loss for people with diabetes, Phase III trial finds

A recent Phase III clinical trial, TRIUMPH-2, evaluated the efficacy and safety of retatrutide, a triple receptor agonist and experimental once-weekly injection being developed to treat obesity and type 2 diabetes. What sets ...

Yo-yo dieting may pose different risks depending on starting weight

Is it harmful to your health to lose weight repeatedly and then gain it back again? In a recent article in Nature Reviews Endocrinology, DZD researchers Norbert Stefan and Faidon Magkos of the University of Copenhagen offer ...

Understanding adult obesity

Obesity is one of the most common health conditions in the world and one of the most misunderstood. Today, it affects about 4 in 10 U.S. adults, and the numbers keep rising.